FS KKR Capital Corp
FSKNYSEOther · MD · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $120.0M | $173.0M | $696.0M | $92.0M | $1.51B |
| Total assets | $13.73B | $14.22B | $15.47B | $16.12B | $17.23B |
| Total liabilities | $7.88B | $7.60B | $8.62B | $9.11B | $9.50B |
| Equity | $5.85B | $6.62B | $6.85B | $7.01B | $7.73B |
| EPS (diluted) | $0.43 | $0.62 | $2.48 | $0.32 | $7.16 |
| Shares out. | 280.1M | 280.1M | 281.2M | 281.7M | 284.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 2.1%
- Return on assets
- 0.9%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 57.4%
- Debt / equity
- 1.35×
- Book value / share
- $20.88
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −30.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −3.4%clean
- Piotroski F-Score
- 4/6mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 good- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 13.0M | 2.9 | -17.2% |
| Apr 30, 2026 | 15.7M | 5.4 | +13.1% |
| Apr 15, 2026 | 13.8M | 3.8 | +9.3% |
| Mar 31, 2026 | 12.7M | 2.9 | +18.3% |
| Mar 13, 2026 | 10.7M | 1.9 | +14.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 18, 2026
- Unregistered equity saleMay 12, 2026
- Entered a material agreement · Results of operations · Regulation FD disclosureMay 11, 2026
- Regulation FD disclosureApr 28, 2026
- Regulation FD disclosureApr 10, 2026
- Results of operationsApr 9, 2026
- Regulation FD disclosureMar 24, 2026
- Regulation FD disclosureMar 5, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 424B2Jun 1, 2026
- SC 14D9/AMay 22, 2026
- SC TO-T/AMay 22, 2026
- 8-KFORM 8-KMay 18, 2026
- 40-33/AMay 15, 2026
- 40-33May 14, 2026
- 8-KFORM 8-KMay 12, 2026
- SC 14D9May 12, 2026
- SC TO-TMay 12, 2026
- SC TO-CMay 11, 2026
- 10-QMay 11, 2026
- 8-KFORM 8-KMay 11, 2026
- DEFA14AMay 5, 2026
- DEFA14AApr 30, 2026
- DEFA14AApr 30, 2026